Ambe, Wilma A.
HRN: 24-03-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/03/2023
11/11/2023
IV
600mg
QID
DM Foot
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes